Content about Anxiolytics

July 18, 2012
Mylan, Somaxon settle insomnia drug suit

Mylan has settled a patent litigation suit filed by Somaxon Pharmaceutical concerning an insomnia drug, Mylan said.

June 13, 2012
Merck releases positive phase-3 data regarding promising insomnia remedy suvorexant

Merck on Wednesday released new data from two pivotal Phase III efficacy trials for suvorexant, the investigational medicine Merck is developing for the treatment of insomnia.

January 31, 2012
FDA approves Hi-Tech Pharmacal's anxiety drug

The Food and Drug Administration has approved a generic drug for anxiety made by Hi-Tech Pharmacal, the drug maker said Tuesday.

November 23, 2011
FDA approves first drug for insomnia with middle-of-night waking, difficulty returning to sleep

The Food and Drug Administration has approved the first drug for insomnia in which patients wake in the middle of the night and have trouble returning to sleep.

October 4, 2011
Insomnia treatment under consideration for Rx-to-OTC switch

Insomnnia may be the next big treatment regimen to make a switch from prescription-only to over the counter.

October 4, 2011
Report: Supreme Court rejects Mylan appeal

Mylan must pay $77 million to four health insurers over allegations that it sought to control the market on ingredients used for two anti-anxiety medicines, according to published reports.

June 7, 2011
Actavis granted final approval for generic Ambien CR

The Food and Drug Administration has given final approval to a generic drug for insomnia made by Actavis, the drug maker said Monday.

February 4, 2011
ECR launches Zolpimist

Hi-Tech Pharmacal subsidiary ECR Pharmaceuticals has launched a drug for treating insomnia.

January 31, 2011
Transcept announces PDUFA action date for Intermezzo

Transcept announced Monday that the Food and Drug Administration has classified the drug maker's insomnia treatment as a complete class-2 response, and assigned the drug a Prescription Drug User Fee Act action date for this summer.

January 18, 2011
Transcept seeks regulatory approval for Intermezzo

Transcept Pharmaceuticals has resubmitted its regulatory application for a drug to treat insomnia to the Food and Drug Administration, following a previous denial of approval by the agency, the drug maker said Tuesday.

October 18, 2010
FDA approves Actavis' generic Ambien CR

The Food and Drug Administration has approved a drug for treating insomnia made by Actavis,...

September 6, 2010
Silenor now available by prescription

Drug maker Somaxon Pharmaceuticals has made its treatment for insomnia available by prescription, the company...

June 15, 2010
FDA approves generic Lorazepam Intensol

The Food and Drug Administration has approved a generic drug for anxiety disorder made by...

May 25, 2010
Mylan launches generic insomnia treatment

Mylan has launched a generic short-term treatment for insomnia, the generic drug maker said Tuesday....

March 17, 2010
FDA approves anxiety disorder generic

The Food and Drug Administration has approved a generic anxiety drug made by Actavis, the...

© 2013 Drug Store News. All Rights Reserved.